Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066) [Phase 3]
Phase 3 clinical trial update evaluating the safety of etoricoxib in osteoarthritis and rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072) [Phase 3]
Phase 3 trial comparing an investigational drug to an approved drug in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis [Phase 3]
An extension study (Phase 3) in participants with moderate to severe rheumatoid arthritis has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) [Phase 3]
Long-term evaluation results from a Phase 3 trial of sarilumab in rheumatoid arthritis have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants [Phase 1]
Phase 1 study evaluating potential OATP-mediated drug-drug interactions between filgotinib and statins in healthy participants; completed wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid Arthritis
A completed clinical trial follow-up study evaluating anti-carbamylated antibody status in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate [Phase 2]
Phase 2 trial evaluating brodalumab (AMG 827) in rheumatoid arthritis patients with inadequate response to methotrexate has completed with r…
-
CLINICAL_TRIALS trial_result · 2021-12-16Clinical Trial Update: PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 study assessing pharmacokinetic similarity in rheumatoid arthritis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Early Changes in Pain, Disease Activity, and Ultrasound Evidence of Inflammatory Synovitis in Patients Receiving JAK-inhibitor vs. TNF-inhibitor Therapy for Active Rheumatoid Arthritis: A Feasibility Study. [Phase 4]
Phase 4 feasibility study comparing JAK-inhibitor versus TNF-inhibitor therapy for rheumatoid arthritis, focusing on early changes in pain, …
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate [Phase 3]
A Phase 3 trial update on discontinuing methotrexate in rheumatoid arthritis patients who achieve remission with upadacitinib plus methotrex…
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate [Phase 2]
Phase IIb dose-ranging trial of BMS-945429 in methotrexate-not-responsive rheumatoid arthritis completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis [Phase 1, Phase 2]
Clinical trial update for AMG 827 in adults with rheumatoid arthritis across phase 1 and phase 2, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) [Phase 2]
Phase 2 trial assessing safety and effectiveness of the Live Zoster Vaccine in patients using anti-TNF therapy for inflammatory diseases, wi…
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate [Phase 3]
A Phase 3 trial comparing BAT1806 to RoActemra in rheumatoid arthritis patients with inadequate response to methotrexate has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update for BCD-089 (aIL6R) in seropositive rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis [Phase 3]
A Phase 3 study comparing CT-P17 to Humira in active rheumatoid arthritis has completed; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis [Phase 3]
A completed Phase 3 trial evaluating the usability of a subcutaneous auto-injector for CT-P17 in patients with active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: Non-inferiority of Reduced-dose Rituximab in Rheumatoid Arthritis in Low Disease Activity and Remission [Phase 4]
Phase 4 trial update shows non-inferiority of reduced-dose Rituximab in rheumatoid arthritis patients with low disease activity or in remiss…
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate [Phase 3]
Phase 3 trial evaluating efficacy and safety of the selective JAK1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequ…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis [Phase 4]
Phase 4 trial update on ticagrelor in methotrexate-resistant rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis [Phase 2]
A Phase 2 trial evaluating the EP4 antagonist CR6086 combined with methotrexate in DMARD-naïve patients with early rheumatoid arthritis has …
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: TL011 in Severe, Active Rheumatoid Arthritis Patients [Phase 1]
Phase 1 trial update for TL011 in severe, active rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients [Phase 2]
Phase 2 trial update for SHR0302 tablets as monotherapy in active rheumatoid arthritis (RA) has been completed.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Evaluation of the Condition of Rheumatoid Arthritis After Treatment [Phase 4]
Phase 4 clinical trial update evaluating the condition of rheumatoid arthritis after treatment.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Usefulness of Non TNF Usage in RA Patients [Phase 2]
Phase 2 trial investigating the usefulness of non-TNF therapies in rheumatoid arthritis.